Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896906661> ?p ?o ?g. }
- W2896906661 endingPage "565" @default.
- W2896906661 startingPage "556" @default.
- W2896906661 abstract "Abstract Aim Several drugs have been used for treating non-alcoholic fatty liver disease (NAFLD). The present study is a network meta-analysis of such drugs. Design, setting and patients Randomised clinical trials comparing drug interventions in patients with NAFLD were analysed. OR and weighted mean difference (95 % CI) were the effect estimates for categorical and numerical outcomes, respectively. Random-effects model was used to generate pooled estimates. Surface under the cumulative ranking curve was used to rank the treatments. Main outcome measures Proportion of responders was the primary outcome measure and non-alcoholic steatohepatitis scores, liver enzymes, lipid profile, body mass index, homeostatic model assessment of insulin resistance, intrahepatic fat and adverse events were the key secondary outcomes. Results 116 studies were included in the systematic review and 106 in the meta-analysis. Elafibranor, gemfibrozil, metadoxine, obeticholic acid, pentoxifylline, pioglitazone, probiotics, telmisartan, vildagliptin and vitamin E significantly increased the response rate than standard of care. Various other drugs were observed to modify the secondary outcomes favourably. Probiotics was found with a better response in children; and elafibranor, obeticholic acid, pentoxifylline and pioglitazone in patients with type 2 diabetes mellitus. The quality of evidence observed was either low or very low. Conclusion In patients with NAFLD, several drugs have been shown to have variable therapeutic benefit. However, the estimates and the inferences should be considered with extreme caution as it might change with the advent of future head-to-head clinical trials." @default.
- W2896906661 created "2018-10-26" @default.
- W2896906661 creator A5004698907 @default.
- W2896906661 creator A5020721733 @default.
- W2896906661 creator A5026382468 @default.
- W2896906661 creator A5056679184 @default.
- W2896906661 date "2018-10-01" @default.
- W2896906661 modified "2023-09-25" @default.
- W2896906661 title "Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis" @default.
- W2896906661 cites W1034730247 @default.
- W2896906661 cites W1617328014 @default.
- W2896906661 cites W1622799587 @default.
- W2896906661 cites W1866142084 @default.
- W2896906661 cites W1888437623 @default.
- W2896906661 cites W1929380714 @default.
- W2896906661 cites W1968396962 @default.
- W2896906661 cites W1969342962 @default.
- W2896906661 cites W1970224691 @default.
- W2896906661 cites W1973401573 @default.
- W2896906661 cites W1975453003 @default.
- W2896906661 cites W1976571856 @default.
- W2896906661 cites W1980245616 @default.
- W2896906661 cites W1988981256 @default.
- W2896906661 cites W1990055069 @default.
- W2896906661 cites W1990168800 @default.
- W2896906661 cites W1991974999 @default.
- W2896906661 cites W2000275607 @default.
- W2896906661 cites W2007516026 @default.
- W2896906661 cites W2013991546 @default.
- W2896906661 cites W2016993385 @default.
- W2896906661 cites W2018152768 @default.
- W2896906661 cites W2019810874 @default.
- W2896906661 cites W2021182659 @default.
- W2896906661 cites W2022296797 @default.
- W2896906661 cites W2022693320 @default.
- W2896906661 cites W2028160831 @default.
- W2896906661 cites W2028236765 @default.
- W2896906661 cites W2030871051 @default.
- W2896906661 cites W2034509216 @default.
- W2896906661 cites W2034604842 @default.
- W2896906661 cites W2036919886 @default.
- W2896906661 cites W2039800528 @default.
- W2896906661 cites W2046604820 @default.
- W2896906661 cites W2049633956 @default.
- W2896906661 cites W2052981488 @default.
- W2896906661 cites W2053285232 @default.
- W2896906661 cites W2054182494 @default.
- W2896906661 cites W2056347555 @default.
- W2896906661 cites W2059196301 @default.
- W2896906661 cites W2059643846 @default.
- W2896906661 cites W2060963949 @default.
- W2896906661 cites W2062812115 @default.
- W2896906661 cites W2065655717 @default.
- W2896906661 cites W2068129913 @default.
- W2896906661 cites W2068166362 @default.
- W2896906661 cites W2069354135 @default.
- W2896906661 cites W2070762302 @default.
- W2896906661 cites W2071550553 @default.
- W2896906661 cites W2074601722 @default.
- W2896906661 cites W2078046698 @default.
- W2896906661 cites W2080725795 @default.
- W2896906661 cites W2086657341 @default.
- W2896906661 cites W2088013434 @default.
- W2896906661 cites W2096064097 @default.
- W2896906661 cites W2097677758 @default.
- W2896906661 cites W2098686608 @default.
- W2896906661 cites W2099459065 @default.
- W2896906661 cites W2100093159 @default.
- W2896906661 cites W2102061487 @default.
- W2896906661 cites W2103156933 @default.
- W2896906661 cites W2106768039 @default.
- W2896906661 cites W2107068945 @default.
- W2896906661 cites W2107453802 @default.
- W2896906661 cites W2109836724 @default.
- W2896906661 cites W2111999709 @default.
- W2896906661 cites W2112967799 @default.
- W2896906661 cites W2114992666 @default.
- W2896906661 cites W2116393673 @default.
- W2896906661 cites W2119912578 @default.
- W2896906661 cites W2122860085 @default.
- W2896906661 cites W2126930838 @default.
- W2896906661 cites W2129821518 @default.
- W2896906661 cites W2130955150 @default.
- W2896906661 cites W2134589202 @default.
- W2896906661 cites W2138306815 @default.
- W2896906661 cites W2139112405 @default.
- W2896906661 cites W2142636360 @default.
- W2896906661 cites W2142844314 @default.
- W2896906661 cites W2148986188 @default.
- W2896906661 cites W2149425072 @default.
- W2896906661 cites W2154075360 @default.
- W2896906661 cites W2154164735 @default.
- W2896906661 cites W2156312046 @default.
- W2896906661 cites W2157671355 @default.
- W2896906661 cites W2158225596 @default.
- W2896906661 cites W2169881063 @default.
- W2896906661 cites W2176182949 @default.
- W2896906661 cites W2207100755 @default.